SCHEMBL13545189

SCHEMBL13545189

CCC(=O)c1ccc(-c2ccccc2NS(C)(=O)=O)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 1/20 0.53
MAPT P10636 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
KDM1A O60341 1/20 0.51
KMT2A Q03164 1/20 0.46
CDK1 P06493 1/20 0.45
CDK2 P24941 1/20 0.45
IRAK4 Q9NWZ3 1/20 0.45
ALOX5AP P20292 2/20 0.44
FEN1 P39748 2/20 0.44
TDP1 Q9NUW8 1/20 0.43
PTGS2 P35354 1/20 0.42
METAP2 P50579 1/20 0.41
HSD17B10 Q99714 2/20 0.40
CA12 O43570 1/20 0.40
CA2 P00918 1/20 0.40
LMNA P02545 1/20 0.40
CA9 Q16790 1/20 0.40
MCOLN3 Q8TDD5 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2040317 0.84 MCL1 (0.64) MCL1SMN1; SMN2L3MBTL1KDM1AKMT2A
SCHEMBL13543265 0.80 MCL1 (0.53) MCL1MAPTSMN1; SMN2KDM1AKMT2A
SCHEMBL4667179 0.79 MCL1 (0.61) MCL1MAPTSMN1; SMN2L3MBTL1KDM1A
SCHEMBL31645593 0.78 KDM1A (0.60) MCL1SMN1; SMN2L3MBTL1KDM1AKMT2A
SCHEMBL4533547 0.78 KDM1A (0.60) MCL1SMN1; SMN2L3MBTL1KDM1AKMT2A
SCHEMBL7183442 0.77 LMNA (0.64) MCL1MAPTSMN1; SMN2L3MBTL1KDM1A
SCHEMBL4535022 0.76 KDM1A (0.53) MCL1L3MBTL1KDM1AKMT2ACDK1
SCHEMBL7183438 0.75 KDM1A (0.58) MCL1SMN1; SMN2L3MBTL1KDM1AKMT2A
SCHEMBL1474479 0.75 HPGD (0.63) SMN1; SMN2KMT2APTGS2LMNAHTT
SCHEMBL23864381 0.74 KDM1A (0.51) MCL1L3MBTL1KDM1ACDK1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7645771-B2 CCR5 antagonists as therapeutic agents SMITHKLINE BEECHAM CORP. (US) 2010-01-12 US disclosed